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Introduction
We propose permutation tests based on the matrix of pairwise
distances between microarrays to compare location, variability, or
equivalence of gene expression between two populations. These
tests can be applied to the entire genome or any subset of genes of
interest. Thus they can be used as global tests of difference in gene
expression or as a testing method applicable to gene set analysis.
These tests have several advantages over permutation tests
based directly on the gene expression data. First, they are not
computationally intensive because they reduce the high dimen-
sional expression data to the low dimensional distance matrix and
this only has to be done once. Second, this same reduction in
dimensionality results in a reduction in the dimensionality of the
potential nuisance parameters. Thus, the assumption of exchange-
ability between groups, which ensures the validity of the
permutation test, only has to apply to the pairwise distances not
to the entire microarray.
Many gene expression studies are designed to detect differential
gene expression in two clinical or biological populations. Interest
may focus on individual genes, specified groups of genes, or all
genes sampled by a particular microarray. Early efforts were
devoted to individual gene analysis [1]. A variety of test statistics
were proposed and an eventual consensus emerged on the use of
false discovery rate estimation to correctly account for multiple
testing [2].
In order to incorporate existing biological information into the
analysis of differential gene expression more recent work has been
devoted to methods that treat sets of related genes as the unit of
analysis [3]. Many methods and tools have been developed to
analyze sets of genes [4,1,5]. These include methods which base
inference on lists of genes which individually exceed a specified cut
off threshold for significance and those which base inference on
scores which combine information over the entire gene set [5].
Further, gene set methods can be divided into competitive and
self-contained tests [3]. Competitive tests compare the specified
gene set to the remaining genes outside the set while self-contained
tests depend only on the specified genes. Competitive tests have
been shown to be conceptually flawed [3] and will not be
considered further.
A number of self-contained, multivariate, tests have been
proposed [6,7,8]. Any multivariate test requires a test statistic
which aggregates information over all genes in the gene set and a
method of inference to determine if the observed magnitude of the
test statistic is extreme under the null hypothesis of no between
group difference in gene expression. The primary challenge in
developing these multivariate tests is posed by having relatively few
samples and many genes. In particular, asymptotic methods may
not be applicable and the sample gene covariance matrix may not
be full rank and is therefore not invertible.
Kong et al. [7] discuss several modifications to Hotelling’s T2 [9]
and suggest reducing the gene set to the lower dimensional
subspace of principal components in which the sample gene
covariance matrix becomes invertible. A permutation test is used
for inference.
Goeman et al. [6] circumvent the problem of inverting the
sample gene covariance matrix by developing a test statistic
derived from a score test for a logistic regression model. In this
model the gene expression values are considered to be fixed
constants and the group indicator variable is considered to be
stochastic. Their statistic is proportional to Hotelling’s T2 under
the assumption of equal variance and zero covariance across all
genes. They present the statistic’s asymptotic distribution but
suggest a permutation test for inference in small samples.
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Hummel et al. [8] propose a test statistic which combines
residual sums of squares from gene-wise linear regression models,
which may include additional covariates of interest, fit with and
without the group effect. They present the asymptotic distribution
of the test statistic under the assumption that the genes follow a
multivariate normal distribution and use a shrinkage estimator to
regularize the sample gene covariance matrix. They also propose a
permutation test based on the residual gene expression derived by
regressing out an intercept and the additional covariates gene by
gene. In the absence of additional covariates, the resulting statistic
can be shown to be permutationally equivalent to Hotelling’s T2
under the assumption of equal variance and zero covariance across
all genes. Note that two statistics are permutationally equivalent
[10] if they have the same (or reverse) ordering over all
permutations and therefore always give the same permutation p-
value.
In this paper we propose methods to test for a significant
difference in gene expression between two study groups based on
the matrix of pairwise distances between microarrays. In the
following sections we present the test statistics given the
assumption of Euclidean distance, additive errors, and a
completely randomized design. We also present an application
to respiratory recovery in trauma patients and extensions to paired
and blocked designs as well as the use of a distance measure based
on correlation.
Methods
Introduction
Consider an experiment comparing gene expression in two
populations. The gene expression values, or some function of the
gene expression values which measures the biological signal for
each gene, can be represented by two groups of column vectors.
We will represent these column vectors by X1,1, . . . ,X1,N1 and
X2,1, . . . ,X2,N2 , for groups 1 and 2 respectively where N1 and N2
are the number of arrays in groups 1 and 2 respectively. For
simplicity we will refer to these vectors as microarrays. Let
D½Xi,j ,Xk,l  be the dissimilarity or distance between two micro-
arrays.
Inference concerning the location and variability of groups 1
and 2 can be based on the three means:
D11~
2
N1(N1{1)
X
ivjƒN1
D X1,i,X1,j
  ð1Þ
D22~
2
N2(N2{1)
X
ivjƒN2
D X2,i,X2,j
  ð2Þ
D12~
1
N1N2
X
iƒN1,jƒN2
D X1,i,X2,j
  ð3Þ
Where
1. D11 is the mean distance between microarrays within group 1.
2. D22 is the mean distance between microarrays within group 2.
3. D12 is the mean distance between microarrays between groups
1 and 2.
Additive Errors and Euclidean Distance
In this section we derive the expected value of D11, D22, and
D12 assuming a completely randomized design, an additive error
model, and squared Euclidean distance. Under these assumptions
we have:
X1,i~m1ze1,i ð4Þ
X2,i~m2ze2,i ð5Þ
where m1 and m2 are the respective mean vectors of the
microarrays in groups 1 and 2 and e1,i and e2,i are random error
vectors with expected value 0 and variance covariance matrices S1
and S2 respectively. The errors are assumed to be independent
across microarrays.
The squared Euclidean distance between any two microarrays,
Xi,j and Xk,l is
Xi,j{Xk,l
 2~ Xi,j{Xk,l T Xi,j{Xk,l  ð6Þ
and a simple calculation yields
E D11½ ~2Tr S1½  ð7Þ
E D22½ ~2Tr S2½  ð8Þ
E D12½ ~ m1{m2j j2zTr S1½ zTr S2½  ð9Þ
where Tr½ is the trace operator which gives the sum of the
diagonal elements of a matrix.
We can now define a test statistic to compare the location or
variability of groups 1 and 2.
To compare location let:
Dl~D12{
D11zD22
2
ð10Þ
To compare variability let:
Dv~D11{D22 ð11Þ
These test statistics have expected values:
E½Dl ~ m1{m2j j2 ð12Þ
and:
E Dv½ ~2 Tr S1½ {Tr S2½ ð Þ ð13Þ
Inference concerning the magnitude of Dv and Dl can be made
using a permutation test. Each permutation consists of assigning
N1 microarrays to group 1 and the remaining N2 to group 2. Note
Significance in Microarray
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that for each permutation the pairwise distances are simply re-
indexed, they do not have to be recalculated. Only the values of
D11, D22, and D12 and Dv and Dl have to be recalculated based on
the re-indexing.
Let Dobsv and D
obs
l be the observed values of Dv and Dl and let D

v
and Dl be the values from a permutation. If there are a total of B
permutations, and assuming Dobsv w0, then
pv~
Number Dv§D
obs
v
 
B
ð14Þ
is a one-sided p-value [11] for rejecting the null hypothesis that
Tr½S1~Tr½S2. If Dobsv v0 then the inequality in Equation 14 is
simply reversed. Similarly
pl~
Number Dl§D
obs
l
 
B
ð15Þ
is a one-sided p-value for rejecting the null hypothesis that m1~m2.
Sometimes investigators design an experiment to compare a
new technical method, such as sample preparation or target
hybridization, to a proven ‘‘gold standard’’. In such an experiment
interest centers on showing that the new method is equivalent to
the gold standard. To be equivalent it should not differ in mean
and not exhibit greater variability. Assuming that the microarrays
in group 1 were prepared using the gold standard, a summary
statistic which can be used to reject the null hypothesis of
equivalence is given by:
De~D12{D11 ð16Þ
If this statistic is large, then group 2 either has a different mean or
more variability than group 1. This can easily be seen from its
expected value under mean squared Euclidean distance:
E De½ ~ m1{m2j j2z Tr S2½ {Tr S1½ ð Þ ð17Þ
Inference concerning the magnitude of De can also be made using
a permutation test. It should be noted that the statistics Dv, Dl, and
De are all special cases of Mantel’s U statistic [12], for which he
derives the permutation variance, and Dl is similar to a special case
of the MRPP statistic [13].
Paired Design
In this section we consider modifications to the test statistics and
permutation test to account for pairing in the experimental design.
We still assume an additive error model and squared Euclidean
distance.
Suppose the experimental design is paired so that each
microarray in group 1 is paired with a microarray in group 2.
In this case N1~N2~N and we assume that
X1,i~m1zBize1,i ð18Þ
X2,i~m2zBize2,i ð19Þ
where Bi is a random vector, independent of all other quantities,
with expected value 0 and variance covariance matrix SB. The
quantities m1, m2, e1,i, and e2,i are again defined as in Section.
To account for the pairing we drop the within pair distance in
our test statistics since it will be systematically less than the
between pair distances. Thus we re-define D12 as:
D12~
1
N2
X
i=j
D X1,i,X2,j
  ð20Þ
then:
E½D11~2Tr½S1z2Tr½SB ð21Þ
E½D22~2Tr½S2z2Tr½SB ð22Þ
E½D12~ m1{m2j j2zTr½S1zTr½S2z2Tr½SB ð23Þ
so that Dv and Dl still have the same expected values given in
Equations 13 and 12.
For this paired design, only paired microarrays are exchange-
able and the permutation test must respect this structure. Thus, a
permutation consists of exchanging microarrays across groups 1
and 2 within each pair of an arbitrary subset of paired
microarrays.
Blocked Design
In this section we consider modifications to the test statistics and
permutation test to account for blocking in the experimental
design. We still assume an additive error model and squared
Euclidean distance.
Suppose the experiment consists of K blocks of related
microarrays. In this case N1,k and N2,k are the number of
microarrays in block k in group 1 and 2 respectively. We also
assume that for blocks k~1, . . . ,K
X1,i,k~m1zBkze1,i ð24Þ
X2,i,k~m2zBkze2,i ð25Þ
where Bk is a random vector , independent of all other quantities,
with expected value 0 and variance covariance matrix SB. The
quantities m1, m1, e1,i, and e2,i are again defined as in Section.
For this blocked design we need to modify the mean distances
D11, D22, and D12 so that they depend only on within block
distances. That is:
D11~
1
N11
XK
k~1
X
ivjƒN1,k
D X1,i,k,X1,j,k
  ð26Þ
D22~
1
N22
XK
k~1
X
ivjƒN2,k
D X2,i,k,X2,j,k
  ð27Þ
D12~
1
N12
XK
k~1
X
iƒN1,k ,jƒN2,k
D X1,i,k,X2,j,k
  ð28Þ
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where:
N11~
1
2
XK
k~1
N1,k N1,k{1ð Þ ð29Þ
N22~
1
2
XK
k~1
N2,k N2,k{1ð Þ ð30Þ
N12~
XK
k~1
N1,kN2,k ð31Þ
The permutation test for this design must respect the blocked
structure. Microarrays are exchanged across groups only within
each block.
Negative Log Correlation Distance
There are various possible measures of distance between
microarrays besides squared Euclidean distance. In this section
we consider a measure based on the Pearson product moment
correlation [14] which we will denote by cor½:. Assuming an
additive error model and a completely randomized design, the
correlation between two microarrays, Z1~m1ze1 and
Z2~m2ze2, is
cor½Z1,Z2~ cov½m1,m2zcov½m1,e2zcov½m2,e1zcov½e1,e2ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
s2m1z2cov½m1,e1zs^2e1
q ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
s2m2z2cov½m2,e2zs^2e2
q ð32Þ
where cov½: is the sample covariance, s2 is the variance, and s^2
is the sample variance. By dividing the numerator and
denominator in Equation 32 by sm1sm2 and rearranging some
terms we get:
cor Z1,Z2½ ~ cor m1,m2½ zdð Þ
ffiffiffiffiffiffi
R^1
q ffiffiffiffiffiffi
R^2
q
ð33Þ
where R^i is the sample estimate of the reliability [15]
Ri~
s2mi
s2mizs
2
ei
ð34Þ
and
d~
cov½m1,e2zcov½m2,e1zcov½e1,e2
sm1sm2
ð35Þ
with E[d] = 0.
If the correlation is positive and under the assumption that
E[d2] is negligibly small then, if we define the distance between Z1
and Z2 by
D½Z1,Z2~{logcor½Z1,Z2 ð36Þ
then, the expected value of D[Z1, Z2] is approximated by
{logcor½m1,m2{
E½logR^1zE½logR^2
2
ð37Þ
Defining Dv and Dl as above in Equations 11 and 10, these test
statistics have expected values
E Dv½ ~E log R^2
R^1
" #
ð38Þ
and
E½Dl ~{logcor½m1,m2 ð39Þ
so that Dv estimates the log of the between group reliability ratio
and Dl estimates the negative log of the correlation between the
group means.
Using the negative log correlation distance the three designs
considered above need no modification except in the interpreta-
tion of the statistics Dv and Dl as presented in Equations 38 and 39.
In the paired design it is convenient to think of the random pair
effect, Bi , as being absorbed in the error term. In the blocked
design it is convenient to think of the random block effect, Bk , as
being absorbed in the mean.
Note that the reliability given by Equation 34, which can be
interpreted as a signal to noise ratio, is a reasonable measure of the
within group distance or variability, but it depends on both the
mean, m, and the error, e. Thus a significant difference in the
within group distance as measured by Dv can be due to a difference
in either the mean or the error.
A commonly used distance measure is one minus the correlation
between microarrays. This distance measure is nearly equivalent
to the negative log correlation distance for values of the correlation
near one. However, by using this distance, the corrected distance
between groups, Dl, does not have the correct expected value and
does not estimate the error free distance between the groups.
Permutation Test Assumptions
Permutation tests may place weaker distributional assumptions
on the data than do parametric tests but they are not totally free of
assumptions. In general they only test the global null hypothesis,
H0 : F1~F2 where F1 is the data generating distribution for group
1 and F2 is the data generating distribution for group 2. In
particular they cannot test that a specific parameter of the data
generating distribution differs between two groups without highly
restrictive assumptions about the remaining (nuisance) parameters.
They do have the desirable property of being exact tests
provided that, under the null hypothesis, the observations are
exchangeable so that the joint distribution of the combined data
set is invariant under permutations of the observation labels. The
permutation tests we propose first reduce the extremely high
dimensionality of the data (and attendant high dimensionality of
the nuisance parameters) to the low dimensional matrix of pairwise
distances. Since inference is based solely on the distribution of
these distances the global null hypothesis becomes the much less
restrictive assumption that the pairwise distances are identically
distributed. Thus, only pairwise distances need be exchangeable
by permutation of observation labels.
In particular, under Euclidean distance and the additive error
model proposed above, the location permutation test, which tests
the null hypothesis, H0 : m1~m2, is exact under the relatively weak
Significance in Microarray
PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e5838
Figure 1. Heat Map
doi:10.1371/journal.pone.0005838.g001
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assumption that the inner product of any two distinct error terms is
exchangeable. That is, the test is exact if terms of the form
(ei,j)
T (ek,l), with fi,jg=fk,lg, are exchangeable across observa-
tions. These scalar terms are easily shown to be simply random
errors in the sense that they each have expected value zero and are
uncorrelated with all other terms.
Results
As an application of our proposed method we analyzed time to
respiratory recovery in ventilated trauma patients in a data set
previously described by Rajicic [16]. Patients were followed for 28
days post trauma and Affymetrix U133+2 microarrays were
prepared from whole white blood cells sampled at days 0, 1, 4, 7,
14, 21, 28. We considered a subset of 48 ventilated patients who
had a day one sample and divided them into two subgroups: those
who recovered from ventilation prior to day seven (early recovery,
N = 22) and those who did not (late recovery, N = 26). Of clinical
interest is the potential association of inflammation on day one and
subsequent respiratory recovery. To address this issue, a set of 445
probesets whose GO annotation included the term ‘‘inflammato-
ry’’ was retrieved for analysis by a keyword search of the
Affymetrix web site (http://www.affymetrix.com/index.affx).
Figure 1 shows a heat map of day one gene expression for the 48
patients (columns) over the 445 probesets (rows). In the figure,
columns labeled with a ‘‘1’’ comprise the early recovery group,
those labeled with a ‘‘2’’ comprise the late recovery group.
Hierarchical clustering using Euclidean distance has been applied
to the patients but not the probesets.
As can be seen in the figure, it is not readily apparent that the
clustering separated the early and late recovery groups. However,
the highest split separated the patients into one group (right hand
side of figure) having 20/38 (53%) early recovery patients while
the remaining group (left hand side off figure) had only 2/10 (20%)
early recovery patients. This imbalance may be suggestive of a
difference in gene expression between the early and late recovery
groups.
To formally test for a group effect we applied our proposed
permutation test for a Euclidean distance location difference
between the early and late recovery groups and obtained a one
sided p-value of 0.0168, indicating a significant difference in gene
expression.
As a check on this result, in the spirit of Kong’s use of
Hotelling’s T-square in the principal component space [7], we
applied MANOVA to the first three principal components. We
obtained a two sided p-value of 0.0393 for the group effect, a result
similar to the permutation test result. The choice of three principal
components was arbitrary, however, and results vary with the
number chosen for analysis.
Figure 2 illustrates the location of the two recovery groups in the
subspace spanned by the first and third principal components.
Note that the same cluster of two early recovery patients (denoted
by ‘‘1’’) and eight late recovery patients (denoted by ‘‘2’’) can be
seen on the right hand side of the figure.
Similar results were obtained using the globaltest R-package of
Goeman et al. [6], with a p-value of 0.0167 as well as the
GlobalAncova R-package of Hummel et al. [8], with a p-value of
0.0210.
Finally it may be of interest to note that, for the remaining
54230 probesets not associated with inflammation, the group
difference was marginally significant with a p-value of 0.0462 by
our method and p-values of 0.0508 and 0.0480 by the methods of
Figure 2. Principal Components
doi:10.1371/journal.pone.0005838.g002
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Goeman and Hummel respectively. This suggests that factors
other than inflammation may also be associated with time to
ventilator recovery.
Discussion
Our proposed test statistics attempt to divide differences in gene
expression into differences in location and differences in variation.
The hope is to find tests for one parameter when the other
parameter differs. This is a common statistical problem that only
has a solution under limited circumstances. For instance, if data
are normally distributed it is possible to find an exact test for
variability differences when there are differences in location but
testing for differences in location when there are differences in
variability is the famous Behrens-Fisher problem which has no
optimal small sample solution [17]. We use permutation tests
because the distribution functions of gene expression are unknown.
The permutation tests we propose have the advantage that the
pairwise distances are calculated before the permutations are
applied so the tests are not computer intensive. The location test is
designed to have power for a location difference and correct Type
I error rate even given a variability difference, and the variability
test is designed to have the opposite characteristics. Simulations
(results not shown) show that, in the cases that we simulated, we
succeeded. However, there may be circumstances where variabil-
ity differences appear as location differences and vice-versa.
Since the distribution functions of gene expression are unknown
it is not possible to calculate the power of the location test under
specified alternative hypotheses. However, as pointed out in the
Introduction, for a two group comparison, both Goeman’s and
Hummel’s methods are permutationally equivalent to Hotelling’s
T2 under the assumption of equal variance and zero covariance
across all genes. This holds true for our location test as well, using
Euclidean distance in a balanced completely randomized design.
Since permutational equivalence holds regardless of the distribu-
tion of the data, in the case of balanced completely randomized
designs all three tests have equal power as permutation tests. In the
moderately unbalanced case, with similar within group variability,
simulations (not shown) show that our test is still nearly
permutationally equivalent to the other two tests so that the
power will be similar.
Our proposed location test is based on the matrix of pairwise
distances between microarrays and is therefore related in a natural
way to cluster analysis which applies an algorithm to the distance
matrix to find clusters in the data. In experimental designs
involving two predetermined groups of microarrays cluster
analysis can be used as a graphical technique to see if the
clustering algorithm ‘‘finds’’ the predetermined groups. Our
proposed method can be thought of as a formal significance test
of whether two predetermined groups form two distinct clusters.
Thus our test is consistent with an intuitive visual display of the
data. Of course applying our location test, or any significance test,
to two groups that were discovered using a clustering algorithm
would be circular and therefore invalid.
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